Sara Hall, Annika Öhrfelt, Radu Constantinescu, Ulf Andreasson, Yulia Surova, Frederick Bostrom, Christer Nilsson, Widner Håkan, Hilde Decraemer, Katarina Någga, Lennart Minthon, Elisabet Londos, Eugeen Vanmechelen, Björn Holmberg, Henrik Zetterberg, Kaj Blennow, Oskar Hansson
OBJECTIVE: To assess the ability of 5 cerebrospinal fluid(CSF) biomarkers to differentiate between common dementia and parkinsonian disorders. DESIGN: A cross-sectional, clinic-based study. PARTICIPANTS: Cerebrospinal fluid samples (N=453) were obtained from healthy individuals serving as controls and from patients with Parkinson disease (PD), PD with dementia(PDD), dementia with Lewy bodies (DLB), Alzheimer disease (AD), progressive supranuclear palsy(PSP), multiple system atrophy (MSA), or corticobasal degeneration (CBD)...
November 2012: Archives of Neurology